Login to Your Account



Lupin, Yoshindo spin out YL Biologics to develop biosimilars in Japan

By Cornelia Zou
Staff Writer

Monday, April 28, 2014
HONG KONG – Indian pharmaceutical company Lupin Ltd. (BSE:500257, NSE:LUPIN) plans to launch a new company dedicated to biosimilars in Japan with its Japanese partner, Toyama-based pharmaceutical Yoshindo Inc.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription